Synmosa Biopharma Corporation (TPEX:4114)
Taiwan · Delayed Price · Currency is TWD 34.85
+0.05 (0.14%)
Sep 5, 2025, 1:30 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2006 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2006 - 2019 |
Generic Drugs | 5.40B | Log In | Log In | Log In | Log In | Upgrade |
Generic Drugs Growth | 8.78% | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients | 153.01M | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients Growth | -14.80% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2006 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2006 - 2019 |
Taiwan | 4.76B | Log In | Log In | Log In | Log In | Upgrade |
Taiwan Growth | 9.00% | Log In | Log In | Log In | Log In | Upgrade |
China | 564.55M | Log In | Log In | Log In | Log In | Upgrade |
China Growth | 5.72% | Log In | Log In | Log In | Log In | Upgrade |
Singapore | 75.89M | Log In | Log In | Log In | Log In | Upgrade |
Singapore Growth | 81.06% | Log In | Log In | Log In | Log In | Upgrade |
Malaysia | 34.36M | Log In | Log In | Log In | Log In | Upgrade |
Malaysia Growth | -5.73% | Log In | Log In | Log In | Log In | Upgrade |
Thailand | 29.70M | Log In | Log In | Log In | Log In | Upgrade |
Thailand Growth | -45.56% | Log In | Log In | Log In | Log In | Upgrade |
United States | 2.21M | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | -92.34% | Log In | Log In | Log In | Log In | Upgrade |
Canada | 2.14M | Log In | Log In | Log In | Log In | Upgrade |
Canada Growth | -86.16% | Log In | Log In | Log In | Log In | Upgrade |
Other | 79.11M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 30.12% | Log In | Log In | Log In | Log In | Upgrade |